Abstract | AIM: METHODS: A human cholangiocarcinoma-derived cell line KKU-M139, which has a naturally high level of endogenous TP, had TP expression transiently knocked down using siRNA. Cell growth, migration, in vitro angiogenesis, apoptosis, and cytotoxicity were assayed in TP knockdown and wild-type cell lines. RESULTS: TP mRNA and protein expression were decreased by 87.1% + or - 0.49% and 72.5% + or - 3.2%, respectively, compared with control cells. Inhibition of TP significantly decreased migration of KKU-M139, and suppressed migration and tube formation of human umbilical vein endothelial cells. siRNA also reduced the ability of TP to resist hypoxia-induced apoptosis, while suppression of TP reduced the sensitivity of KKU-M139 to 5-fluorouracil. CONCLUSION:
|
Authors | Jongkonnee Thanasai, Temduang Limpaiboon, Patcharee Jearanaikoon, Banchob Sripa, Chawalit Pairojkul, Srisurang Tantimavanich, Masanao Miwa |
Journal | World journal of gastroenterology
(World J Gastroenterol)
Vol. 16
Issue 13
Pg. 1631-8
(Apr 07 2010)
ISSN: 2219-2840 [Electronic] United States |
PMID | 20355241
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antimetabolites, Antineoplastic
- RNA, Small Interfering
- Thymidine Phosphorylase
- Fluorouracil
|
Topics |
- Antimetabolites, Antineoplastic
(pharmacology)
- Apoptosis
- Bile Duct Neoplasms
(drug therapy)
- Carcinoma, Squamous Cell
(drug therapy)
- Cell Line, Tumor
- Cell Movement
- Cell Proliferation
- Cholangiocarcinoma
(drug therapy)
- Endothelium, Vascular
(pathology)
- Fluorouracil
(therapeutic use)
- Humans
- Neoplasm Invasiveness
- Neovascularization, Pathologic
- RNA, Small Interfering
(metabolism)
- Thymidine Phosphorylase
(metabolism)
|